HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses.

Abstract
The GM2 gangliosidoses are a group of autosomal recessive lysosomal storage disorders caused by defective β-hexosaminidase. There are three clinical conditions in this group: Tay-Sachs disease (TSD), Sandhoff disease (SD), and hexosaminidase activator deficiency. The three conditions are clinically indistinguishable. TSD and SD have been identified with infantile, juvenile, and adult onset forms. The activator deficiency is only known to present with infantile onset. Diagnosis of TSD and SD is based on decreased hexosaminidase activity and a change in the percentage of activity between isoforms. There are no biochemical tests currently available for activator deficiency. This unit provides a detailed procedure for identifying TSD and SD in affected individuals and carriers from leukocyte samples, the most robust sample type available.
AuthorsPatricia Hall, Sara Minnich, Claire Teigen, Kimiyo Raymond
JournalCurrent protocols in human genetics (Curr Protoc Hum Genet) Vol. 83 Pg. 17.16.1-8 (Oct 01 2014) ISSN: 1934-8258 [Electronic] United States
PMID25271840 (Publication Type: Journal Article)
CopyrightCopyright © 2014 John Wiley & Sons, Inc.
Topics
  • Gangliosidoses, GM2 (diagnosis)
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: